Sign In to Follow Application
View All Documents & Correspondence

Process For The Preparation Of Advantame

Abstract: Process for the Preparation of Advantame : A novelprocess for the preparation of N-[N-[3-(3-hydroxy-4-methoxyphenyl)-propyl]-L-a-aspartyl]-L-phenylalanine-l-methyl ester is described. It comprises, reacting isovanillin or its derivative with vinyl acétate followed by reductive condensation with L-[a-aspartyl]-L-phenylalanine-1-methyl ester.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
20 April 2015
Publication Number
23/2015
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2018-10-03
Renewal Date

Applicants

DIVI'S LABORATORIES LIMITED
7-1-77/E/1/303, DIVI TOWERS, DHARAM KARAN ROAD, AMEERPET, HYDERABAD - 500 016

Inventors

1. MURALI KRISHNA PRASAD DIVI
7-1-77/E/1/303, DIVI TOWERS, DHARAM KARAN ROAD, AMEERPET, HYDERABAD - 500 016
2. MYSORE ASWATHA NARAYANA RAO
7-1-77/E/1/303, DIVI TOWERS, DHARAM KARAN ROAD, AMEERPET, HYDERABAD - 500 016
3. SHAIK NOWSHUDDIN
7-1-77/E/1/303, DIVI TOWERS, DHARAM KARAN ROAD, AMEERPET, HYDERABAD - 500 016

Specification

Field of Invention :

The present invention relates to an improved process for the preparation of N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]-L-a-aspartyl]-L-phenylalanine-l-methyl ester, known as Advantame, a non-caloric sweetener.

Background of the Invention : '

Advantame is a novel sweetener developed by Ajinomoto Co. It is a derivative of Aspartame, chemically N- [N- [3-(3-hydroxy-4-methoxyphenyl)propyl] -L-a- [aspartyl] -L-phenylalanine-1 -methyl ester, having the folíowing structure:

The U.S. Pat. No. 6,794,531 B2, assigned to Ajinomoto Co., describes a process for the preparation of Advantame (Scheme 1), involving condensation of 3-(3-hydroxy-4-methoxyphenyl)-propionaldehyde (III) with Aspartame.


The required propionaldehyde derivative (III) was prepared by selectively reducing the corresponding cinnamic acid derivative (I) by hydrogenation using catalyst-1 consisting of palladium based catalyst, triaryl phosphine and pivalic acid anhydride to obtain corresponding cinnamaldehyde intermediate (II), followed by a second hydrogenation using catalyst-2, which can be any general catalyst based on palladium, platinum, nickel etc. Altematively, (I) was first reduced by hydrogenation using catalyst-2 to obtain (IV) followed by reduction using catalyst-1. The propionaldehyde intermediate (III) was reductively aminated with aspartame to give advantame. Reduction of carboxylic acid of cinnamic acid intermediate to aldehyde using catalyst-1 was cumbersome. Ajinomoto reported a related process in its patent U.S. 6,548,096 Bl (Scheme 2):

In this process, 4-methoxy-3-benzyloxy cinnamaldehyde (Ha) was condensed with benzyl protected aspartame by reductive amination using sodium triacetoxyborohydride to obtain (Va). Hydrogenation of (Va) using palladium catalyst resulted in deprotection of benzyl groups and saturation of tríe double bond to give Advantame. This process requires protection and later deprotection of. both phenolic group of the cinnamaldehyde and carboxylic acid of aspartame through benzylátion, which increases the number of steps and cost of the process. Ajinomoto described another process in U.S. Pat. 7,141,263 B2 (Scheme 3):

In the scheme-3, the first step is cross aldol condensation of isovanillin with acetaldehyde in the presence of an alkali to obtain (3-hydroxy-4-methoxy) cinnamaldehyde (II). Catalytic hydrogenation of (II) gives (III) which on reductive amination with aspartame gives Advantame. Direct reductive condensation of (II) with aspartame also results in Advantame. By this process (II) is obtained in much purer form compared to other processes where the corresponding cinnamic acid derivative is reduced to obtain intermedíate (II) (Scheme 1). However, Scheme-3 process suffers from a major drawback. Cross aldol condensation between acetaldehyde and other carbonyl compound in an alkaline médium generally gives poor yields. This is mainly because of self-condensation of acetaldehyde enolate with unreacted aldehyde resulting in undesirable products and side reactions (Angew. Chem. Int. Ed. Engl. 1968, 7, 7-14; Synthesis 1979, 633-665). The Ajinomoto process (Scheme-3) also suffers for similar reasons. The process attempts to overeóme this problem by slow addition of acetaldehyde to the alkaline solution of isovanillin. But the addition is excruciatingly slow taking about 45 hours (up to 96 hours as per Claim-6) making the process duration very long.

Because of the enumerated drawbacks of the above mentioned processes, there is thus a need for developing an improved process.

Summary of the Invention :

Since acetaldehyde enolate generated from acetaldehyde in the alkaline médium during aldol condensation results in a number of side reactions, it was hypothesized that generating acetaldehyde enolate from a non-aldehyde compound may be able to suppress side reactions during the aldol reaction. Indeed, such was found to be the case when vinyl acétate was used as a non-aldehyde compound to genérate acetaldehyde enolate. The acetaldehyde enolate obtained from vinyl acétate on condensing with isovanillin resulted in highly puré (4-methoxy-3-hydroxy) cinnamaldehyde with good yields.

The present invention describes a novel process for Advantame based on vinyl acétate condensation with isovanillin or O-benzylisovanillin followed by reductive amination with Aspartame (Scheme-4):

Detailed Description of the Invention :

The jpresent invention describes a process (Scheme 4) for the preparation of Advantame which comprises: I. Condensing isovanillin or its O-benzyl derivative with vinyl acétate in the presence of an alkali to obtain cinnamaldehyde derivative (II) or (Ha), II. condensing(II) or (Ha) with aspartame through reductive amination using sodium
borohydride and acetic acid to obtain (V) or (Vb), III. catalytic hydrogenation of (V) or (Vb) to obtain Advantame.

Junjappa et al (Synlett.2000, 9, 1345-1347) reported the preparation of cinnamaldehyde by refluxing a tetrahydrofuran solution of benzaldehyde and vinyl acétate using barium hydroxide as a base. Isolation involved diluting the reaction mixture with water and extraction with chloroform followed by column chromatography for purification. No hydroxyl substituted benzaldehyde was attempted, although other substituted aldehydes were studied. When 2.5 : equivalents of vinyl acétate were used, a dienal (VI) was obtained in 61%.

Our initial attempts to prepare (3-hydroxy-4-methoxy) cinnamaldehyde by the method described by Junjappa et al resulted only in the acetylation of the phenolic group. (Scheme-5):

Change of solvents (acetonitrile, ethanol, methanol, etc) and bases (NaOH, KOH, Et3N etc), did not improve the situation. Henee the phenolic group was protected with benzyl and the resulting O-benzylisovanillin was reacted with vinyl acétate. No reaction was observed at low or room temperature but significant amount of (Ha) was obtained when a solution of O-benzylisovanillin and vinyl acétate in methanol weré autoclaved at 80°C for 12 hours in presence of sodium carbonate. From the reaction mixture the product (Ha) was isolated through column chromatography in about 40% yield. The compoud (Ha) was condensed with aspartame through reductive amination using sodium borohydride and acetic acid and the crude solid obtained was recrystallized from n-hexanes to get puré (Vb) in 78% yield (96% HPLC). Hydrogenation of (Vb) over Pd/C in methanol-water resulted in crude Advantame, which on crystallization from methanol gave puré Advantame in 55% yield (99.6% HPLC).

Although Advantame was obtained in good purity, the yields were poor at the first and final stages. Furthermore, the process involved an additional step of protecting isovanillin through benzylation.

Kown et al (Synthetic Communications, 2004, 34, 1223-1228) reported the preparation of 2-hydroxycinnamaldehyde using the method of Junjappa et al. From 2-hydroxybenzaldehyde and vinyl acétate in acetonitrile as solvent using potassium carbonate as the base they obtained 2-hydroxy cinnamaldehyde in 34% yield together with trace amounts of coumarin (Scheme-6):

Surprisingly no reaction was observed when Ba(OH>2 or t-BuOK was used as the base. With 3-hydroxybenzaldehyde, corresponding cinnamaldehyde was obtained in about 43% yields. With 4-hydroxy benzaldehyde no reaction was observed. The fact that hydroxyl cinnamaldehyde can be obtained without protecting the phenolic group prompted us to explore further the reaction of isovanillin with vinyl acétate.

Systematic and detailed studies of the reaction conditions such as base, solvent, temperature and duration of reaction resulted in optimized reaction conditions where (II) was obtained in high yield and purity (>95% yield, >99.5% HPLC).

Best results were obtained when vinyl acétate was used in three equivalents to isovanillin and the reaction was conducted in water as solvent at -10 ±2°C with 10 equivalent sodium hydroxide as the base. Formation of impurities was high at room temperature. When sodium hydroxide was used in 3 to 6 equivalents, the reaction was incomplete. Similarly, three equivalents of vinyl acétate were required for optimum results. It is interesting to note that no dienal similar to (IV) was formed as reported by Junjappa et al at 2.5 equivalents of vinyl acétate.

Condensation of (II) with aspartame was carried out by reductive amination using sodium borohydride in acetic acid at room temperature. Acetic acid acted both as a reagent and solvent. After the reaction, about 2 hours, the reaction mixture was diluted with water and extracted with ethyl acétate. Removal of the solvent and recrystallization of the residue with methyl f-butyl ether resulted in the compound (V) in 85% yield (>96% HPLC).

The compound (V) was hydrogenated using palladium/carbon catalyst in a mixture of methanol and water. After removal of the solvent, the residue was dissolved in water and extracted with n-butanol. Concentxation of the solution and recrystalhzation from methanol-water mixture resulted in puré Advantame in 72% yield with 99.7% HPLC purity.

The embodiments of the present invention are further described in the following examples, which are not intended in any way to limit the scope of the invention.

Example-1: Preparation of O-benzyl isovanillin :
Isovanillin (lOOg, 0.657 mole) was dissolved in 600 mLwater containing potassium hydroxide (47.9g, 0.8553 mole). Benzyl chloride (109.6g, 0.857 mole) was added drop wise at 10±2°C for 25-30 min. After the addition, the reaction mixture was warmed to room temperature and refluxed for 12 h. After cooling,the aqueous layer was extracted with dichloromethane (3 xlOO mL).After drying the organic layer over Na2SC>4, solvent was distilled at 40°C to get brown thick liquid. It was recrystallized from ethanol to obtain O-benzylisovanillin (Yield: 122.2g, 76.7%, 98.5% HPLC).

Example-2: Preparation of (3-benzyloxy-4-methoxyphenyl)cinnamaldehyde (Ha) :

Benzyl isovanillin (50g, 0.206 mole) was dissolved in 300 mL methanol in an autoclave SS flask. Sodium carbonate (21.87g, 0.20 mole) and vinyl acétate (26.6g, 0.3096 mole) were added to the flask and sealed. The flask temperature was maintained at 80°C for 12hour. After cooling, the content of the flask was collected and the solvent was removed under vacuum to get crude material. It was dissolved in ethyl acétate and washed with water (2 xlOO mL). The ethyl acétate layer was dried over Na2S04 and the solvent was removed under vacuum at 50°C to get brown crude product. It was purified using silica gel column by eluting with a mixture of hexanes and ethyl acétate (7:3 ratio) to obtain (3-benzyloxy-4-methoxyphenyl) cinnamaldehyde, (Yield : 22.2g40.1%).

Example-3: Synthesis of N-[N-[3-(3-benzyloxy-4-methoxyphenyl)propenyl]-L-aspartyl]-L-phenylalanine-1-methyl ester (Vb):

Sodium borohydride (2.4g, 0.0634 mole) was added to acetic acid (28g, 0.465 mole) and stirred at 10±2°C. After about 20 min, the reaction mass turned to a white suspensión. To this was added (3-benzyloxy-4 methoxyphenyl) cinnamaldehyde (5.0g, 0.0186 mole) and aspartame (5.4g, 0.0183 mole) lot wise for 15-20 min at 10±2°C and stirred for 2 hours. Water (50 mL) and ethyl acétate (75 mL), were added. The ethyl acétate layer was separated and washed with saturáted sodium bicarbonate solution. After drying the ethyl acétate layer over Na2SC>4, solvent was distilled under vacuum at 50 C to get crude material. Crystallization using n-hexanes resulted in a yellow solid (Yield: 7.94g, 78%, 96% HPLC)

Example-4: Preparation óf Advantame :
The compound obtained from Example-3 (3.0 g, 0.0054 mole) was dissolved in a solution containing methanol (30 mL) and water (20 mL). Palladium/carbon catalyst (O.lg of 10%) added and the reaction mixture hydrogenated for 12 hours at about 50 psi pressure. After the reaction,the catalyst was filtered and the reaction mass distilled at 50°C to give oily crude material. Crystallization in methanol and water gives off white solid of Advantame (Yield: 1.46g, 55.8%, HPLC 99.6%).

Example-5: Synthesis of (3-hydroxy-4-methoxy) cinnamaldehyde (II):

Isovanillin (25g, 0.164 mole) and sodium hydroxide (65.7g, 1.6425 mole) were dissolved in 400 mL water and the solution was cooled to -10±5°C. To the solution was added vinyl acétate (14!2g, 0.16 mole) drop wise over a period of 30 min and maintained for 12 hours. A second lot of vinyl acétate (14.2g, 0.16 mole) was added and stirred for 6 hours and a third lot was added and stirred for 6 hours. The pH was adjusted to 2.0 with conc.HCl. The yellow solid obtained was filtered and recrystallized using ethanol to obtain(4-methoxy-3-hydroxy) cinnamaldehyde in puré form (Yield : 26.2g, 90.1 %, 99.6% HPLC).

ExampIe-6: Synthesis of Advantame :

. Sodium borohydride (l.Og, 0.02643 mole) was dissolved in 15 mL acetic acid and the solution was cooled to 10±2°C. After 20 min, the solution turned to a white suspensión. To this suspensión was added 4-methoxy-3-hydroxy) cinnamaldehyde (5.0g, 0.02805 mole) and aspartame (7.5g, 0.254 mole), allowed to cool to room temperature and stirred for 2 hours. The content was transferred to a hydrogenation flask and ethanol (30 mL), water (20 mL) and 5% palladium/carbon catalyst (0.5g) were added. Hydrogenation was carried out for 10 hour at about 50 psi. The catalyst was filtered and the solvent removed under vacuum at 50±5°C. The crude oil obtained was dissolved in water and washed with toluene to remove impurities. The aqueous solution was extracted with n-butanol (3 x 25 mL). The butanol layers were pooled and concentrated under vacuum at 50±5°C to get oily crude material. It was recrystallized using methanol-water mixture to obtain advantame in puré form (Yield : 8.82g, 66%, 99.7% HPLC).

Example-7: Synthesis of N-[N-[3-(3-hydroxy-4-methoxyphenyl)propenyl]-L-aspartyl]-L-phenylalanine-1-methyl ester (V) :

Sodium borohydride (l.Og, 0.02643 mole) was added to 15 mL acetic acid and stirred at 10±2°C. After about 20 min, the reaction mass turned to a white suspensión. To this were added (3-benzyloxy-4-methoxyphenyl) cinnamaldehyde (5.0g, 0.0186 mole) and aspartame (7.5g, 0.0255 mole). The reaction mixture was warmed to room tempe.rature and stirred for 2 hours. Water (50 mL) was added and extracted with ethyl acétate (75 mL).The ethyl acétate layer was separated and washed with saturated sodium bicarbonate solution. After drying the ethyl acétate layer over Na2S04, solvent was distilled under vacuum at 50°C to get crude material. Crystallization using methyl tert-butyl ether resulted in puré solid of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propenyl]-L-aspartyl]-L-phenylalanine-l-methyl ester (Yield: 21.Og, 85%, 96.5% HPLC).

Example-8: Synthesis of Advantame :

N-[N-[3-(3-hydroxy-4-methoxyphenyl)propenyl]-L-aspartyl]-L-phenylalanine-l-methyl ester from Example-7 (20.0g, 0.0438 mole) was dissolved in a mixture of methanol (100 mL) and water (20 mL), transferred to a hydrogénation flask. To this was added 5% Palladium/carbon catalyst (0.5g) and hydrogenated for 10 hours at about 50 psi pressure. The catalyst was filtered and the fíltrate was concentrated at 50°C under vacuum to get an oily crude compound. It was dissolved in water and washed with toluene to remove impurities. The aqueous phase was extracted with n-butanol. The n-butanol layer was concentrated at 50°C under vacuum to get crude compound. It was recrystallized using methanol-water mixture to obtain Advantame (Yield: 15.1 g, 72%, 99.7% HPLC).

We Claim:

1. A process for the preparation pf of N-[N-[3-(3-hydroxy-4-methoxyphenyl)-propyl]-L-a-aspartyl] -L-phenylalanine-1 -methyl ester (Advantame) comprising: condensing isoyanillin or O-benzylisovanillin having the following structure: with vinyl acétate having the structure: in aqueous alkaline médium to obtain (3-hydroxy-4-methoxy) cinnamaldehyde (II) or its derivative (Ha) having the structure: Condensing (3-hydroxy-4-methoxy) cinnamaldehyde (II) or its derivative (Ha) with Aspartame having the structure: through reductive amination to obtain a phenylpropenyl derivative of Aspartame (V or Vb) having the structure: and subjecting (V) or (Vb) to catalytic hydrogenation.

2. A process according to claim-1, wherein condensation of isovanillin or 0-benzylisovanillin with vinyl acétate is carried out at a temperature range of -15°to 0 °C.

3. A process according tó claim-1, wherein condensing (4-methoxy-3-hydroxy)cinnamaldehyde (II) or its derivative (Ha) with Aspartame through reductive amination is carried out using sodium borohydride and acetic acid.

4.A process for the preparation of (3-hydroxy-4-methoxy) cinnamaldehyde (II) or its derivative (Ha) by condensing isovanillin or O-benzylisovanillin with vinyl acétate in aqueous alkaline médium.

Documents

Application Documents

# Name Date
1 2019-CHE-2015 FORM-2 20-04-2015.pdf 2015-04-20
2 2019-CHE-2015 FORM-1 20-04-2015.pdf 2015-04-20
3 2019-CHE-2015 DESCRIPTION (COMPLETE) 20-04-2015.pdf 2015-04-20
4 2019-CHE-2015 CORRESPONDENCE OTHERS 20-04-2015.pdf 2015-04-20
5 2019-CHE-2015 CLAIMS 20-04-2015.pdf 2015-04-20
6 2019-CHE-2015 ABSTRACT 20-04-2015.pdf 2015-04-20
7 2019-CHE-2015 FORM-9 28-05-2015.pdf 2015-05-28
8 2019-CHE-2015 FORM-5 28-05-2015.pdf 2015-05-28
9 2019-CHE-2015 FORM-18 28-05-2015.pdf 2015-05-28
10 2019-CHE-2015 CORRESPONDENCE OTHERS 28-05-2015.pdf 2015-05-28
11 2019-CHE-2015-Form 3-280915.pdf 2016-03-28
12 2019-CHE-2015-Correspondence-280915.pdf 2016-03-28
13 2019-CHE-2015-Form 3-290316.pdf 2016-06-08
14 2019-CHE-2015-FER.pdf 2018-04-20
15 Form3_FER Reply_26-09-2018.pdf 2018-09-26
16 Form2 Title Page_FER Reply_26-09-2018.pdf 2018-09-26
17 Form1_FER Reply_26-09-2018.pdf 2018-09-26
18 Correspondence by Applicant_Reply to Examination Report_26-09-2018.pdf 2018-09-26
19 Claims_FER Reply_26-09-2018.pdf 2018-09-26
20 Amended Pages Of Specification_FER Reply_26-09-2018.pdf 2018-09-26
21 Description_Granted 301802_03-10-2018.pdf 2018-10-03
22 Claims_Granted 301802_03-10-2018.pdf 2018-10-03
23 Abstract_Granted 301802_03-10-2018.pdf 2018-10-03
24 2019-CHE-2015-PatentCertificate03-10-2018.pdf 2018-10-03
25 2019-CHE-2015-IntimationOfGrant03-10-2018.pdf 2018-10-03
26 Correspondence by Applicant_Renewal Fee_15-10-2018.pdf 2018-10-15
27 2019-CHE-2015-Correspondence_Renewal Fee_13-03-2020.pdf 2020-03-13
28 2019-CHE-2015_Correspondence_Renewal_23-03-2020.pdf 2020-03-23
29 2019-CHE-2015_Correspondence_Renewal_18-03-2021.pdf 2021-03-18
30 301802-Correspondence_Renewal Fee_09-03-2022.pdf 2022-03-09
31 301802-Correspondence_Renewal Fee_06-03-2023.pdf 2023-03-06

Search Strategy

1 SearchStrategyandreport_13-04-2018.pdf

ERegister / Renewals

3rd: 15 Oct 2018

From 20/04/2017 - To 20/04/2018

4th: 15 Oct 2018

From 20/04/2018 - To 20/04/2019

5th: 15 Oct 2018

From 20/04/2019 - To 20/04/2020

6th: 13 Mar 2020

From 20/04/2020 - To 20/04/2021

7th: 18 Mar 2021

From 20/04/2021 - To 20/04/2022

8th: 09 Mar 2022

From 20/04/2022 - To 20/04/2023

9th: 06 Mar 2023

From 20/04/2023 - To 20/04/2024

10th: 04 Mar 2024

From 20/04/2024 - To 20/04/2025

11th: 03 Mar 2025

From 20/04/2025 - To 20/04/2026